Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1018-2023Class II

Oxford Partial Knee System, Fixed Lateral Tibial Construct- Intended to replace part of a knee joint when...

Zimmer GmbH / initiated 2022-12-15 / Open, Classified / root cause: packaging

Biomet, Inc. began a recall of Oxford Partial Knee System, Fixed Lateral Tibial Construct- Intended to replace part of a knee joint when used in conjunction with a femoral and tibial... on . FDA classified it as Class II and gives the reason as "Packaged in the incorrect shelf carton. Incorrect shelf carton; outer carton is smaller than the required outer carton, which forces the Tyvex pouch to be folded and packaged in the carton causing compound creases and...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-1018-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Zimmer GmbH
Product
Oxford Partial Knee System, Fixed Lateral Tibial Construct- Intended to replace part of a knee joint when used in conjunction with a femoral and tibial component Item Number: 154341
Product code
HRY Prosthesis, Knee, Femorotibial, Semi-Constrained, Cemented, Metal/Polymer
Reason for recall
Packaged in the incorrect shelf carton. Incorrect shelf carton; outer carton is smaller than the required outer carton, which forces the Tyvex pouch to be folded and packaged in the carton causing compound creases and compromise the sterile barrier
Root cause tag
packaging
FDA root cause
Package design/selection
Action
Zimmer Biomet issued Urgent Medical Device Recall Letter on 12/15/22 to Distributors and Risk Managers/Surgeons. Letter states reason for recall, health risk and action to take: Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your Zimmer Biomet sales representative will remove the affected product from your facility. 3. If the product has been further distributed, provide your customers with the notice for hospitals and ensure documentation. 4. Complete Attachment 1 Certificate of Acknowledgement and send to [email protected]. This form shall be returned even if you do not have affected products at your facility. 5. Retain a copy of the acknowledgement form with your recall records in the event of a compliance audit of your facility s documentation. 6. If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to [email protected].
Quantity in commerce
7 units
Distribution
Worldwide distribution - US Nationwide distribution in the states of IN, KY and the countries of Canada, New Zealand, Japan, Netherlands.
Product codes and lots
UDI: (01) 05019279515349 (17) 241123 (10) 077830 Lot Number: 077830

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1018-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1018-2023Class IIOngoingVoluntary: Firm initiated